Alkermes Case Study: Product and Process Transfer of a Low-Solubility Compound with Six-Year OTIF >95%

28 September 2011 by Alkermes Contract Pharma Services

Alkermes, through the merger with Elan Drug Technologies to form Alkermes plc, has been developing and manufacturing commercial-scale solid oral dosage products for over 40 years. This case study demonstrates the successful transfer of a low-solubility compound into one of our manufacturing sites and achieving, as a result, an OTIF (On-Time-In-Full) consistently over 95%.

Download this free white paper to find out more.